The 2012 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for SuppliersVenture Planning GroupMarch 28, 2012 1200 Pages - SKU: VPG3815852 |
|
The World Market for Pain Management Drugs and Devices
5/20/2013 | published by: Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and
|
read more...
|
$3,500.00
|
|
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,
|
read more...
|
$4,500.00
|
|
Bladder Cancer – Executive Market Summary 2013
5/20/2013 | published by: Timely Data Resources, Inc.
The Bladder Cancer Executive Market Summary 2013 provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers and percentages for major countries worldwide, information on diagnosis, and an overview of
|
read more...
|
$950.00
|
|
AbaStar MDx, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary AbaStar MDx, Inc. (AbaStar) is a physiological diagnostics provider. It develops blood-based gene expression and molecular diagnostic tests for the diagnosis of mental disorders and neurodegenerative diseases. The company provides physiological diagnostics from the molecular
|
read more...
|
$750.00
|
|
Alfa Wassermann, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Alfa Wassermann, Inc. (Alfa Wassermann) is a clinical device manufacturer. It designs and manufactures devices and equipment for clinical laboratories and diagnostic centers. The company’s products include medical diagnostic instruments and reagents such as Alera
|
read more...
|
$750.00
|
|
Autoimmune Technologies, LLC - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Autoimmune Technologies, LLC (Autoimmune) is a biomedical company. The company develops medical diagnostic tests, explores disease mechanisms and investigates therapies for autoimmune diseases and disorders. It develops anti-viral drugs that are designed to prevent viral
|
read more...
|
$750.00
|
|
Biomagnetics Diagnostics Corporation (BMGP) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Biomagnetics Diagnostics Corporation (Biomagnetics Diagnostics) is a medical devices and biotechnology company. The company designs, patents and markets diagnostic equipment and immunoassays, and other biotechnologies. Its products include high throughput screening - magnetic testing platform
|
read more...
|
$750.00
|
|
BioTex, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary BioTex, Inc. (BioTex) is a medical technology company. It explores, develops and commercializes novel optical technologies for medical, biomedical, and environmental applications. It develops technologies for both diagnostic and therapeutic medical applications. It undertakes the
|
read more...
|
$750.00
|
|
Focus Diagnostics, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Focus Diagnostics, Inc. (Focus Diagnostics) is a medical device company. The company manufactures and distributes molecular and immunology products. Its products include 3M integrated cycler, simplexa molecular products, herpeselect type, dxselect serology products, serology reagents
|
read more...
|
$750.00
|
|
Great Basin Corporation - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
Summary Great Basin Corporation (Great Basin) is a life science company. The company develops and distributes point-of-care technology and products which improve automation, throughput, scalability, reliability and ease-of-use in rapid diagnostic testing. It develops tests in
|
read more...
|
$750.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
- Diseases & Conditions
- Cancer Treatment
- In Vitro Diagnostics
- Hematology & Oncology
- Life Sciences
- Diagnostics
- Therapeutic Area
- Oncology/Hematology
Oncology/Hematology Reports
- The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
- 2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
- Analytical Tool - Cancer Immunotherapy
- Molecular Diagnostics in Cancer Testing
- Global Next Generation Cancer Diagnostic Devices Market 2012-2016
